Oxford BioTherapeutics
Clinical Stage Oncology Company
- B2B
About Oxford BioTherapeutics
Develops first-in-class immuno-oncology and antibody-drug conjugate therapies, with a lead asset in clinical development. Discovers oncology targets using a proprietary proteomic database.
Key facts
- Industry
- Biotechnology
- Company size
- 51–250 employees
- Headquarters
- Oxford, England, United Kingdom
- Founded
- 2004
- Revenue
- $9.5M – $75.2MTamtam estimate
- Website
- oxfordbiotherapeutics.com
Oxford BioTherapeutics at a glance
Oxford BioTherapeutics is a B2B company in the Biotechnology industry, headquartered in Oxford, England, United Kingdom.
Oxford BioTherapeutics was founded in 2004.
Oxford BioTherapeutics has 51–250 employees.
Oxford BioTherapeutics's revenue is $9.5M – $75.2M (Tamtam estimate).
Selling to companies like Oxford BioTherapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies